Efficacy of a Single Daily Dose of a Nonsteroidal Anti-Inflammatory Drug with an Intermediate Plasma Half-Life: A Double-Blind, Comparative Trial of Acemetacin and Piroxicam
AuthID
P-00J-GY3
P-00J-GY3